Stockscreener 앱 받기
3.00
1.35%
0.04
시간 외 거래:
3.05
0.05
+1.67%
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
JP Morgan Downgrades Rocket Pharmaceuticals (RCKT) - MSN
Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote, News & History - Benzinga
RCKT Should I Buy - Intellectia AI
Rocket Pharmaceuticals (RCKT) CEO logs small stock sale to cover RSU tax obligations - Stock Titan
Rocket Pharmaceuticals (RCKT) counsel sells small stake to cover RSU taxes - Stock Titan
Rocket Pharmaceuticals (RCKT) officer sells 384 shares to cover RSU tax withholding - Stock Titan
Rocket Pharmaceuticals (NASDAQ: RCKT) files Form 144 to sell 55,684 shares - Stock Titan
Rocket Pharmaceuticals shareholders approve board nominees and proposals at annual meeting - Investing.com Canada
Rocket Pharmaceuticals shareholders approve board nominees and proposals at annual meeting By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals Shareholders Approve 2026 Governance Proposals - TipRanks
Rocket Pharmaceuticals (RCKT) investors approve directors, pay and option exchange - Stock Titan
Rocket Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going? - Insider Monkey
Proposed resale of 2,409 Common shares by RCKT filer (Form 144) - Stock Titan
Director resale notice — RCKT (NASDAQ: RCKT) lists 384 shares from vesting - Stock Titan
662-Share Rule 144 Notice for RCKT (NASDAQ: RCKT) - Stock Titan
5 Best Gene Therapy Stocks to Buy in 2026 - Insider Monkey
Rocket Pharmaceuticals, Inc.Common Stock (NQ: RCKT - The Chronicle-Journal
Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M - Insider Monkey
5 Best NASDAQ Stocks Under $5 to Buy Right Now - Insider Monkey
Rocket Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
RCKT Stock Price, Quote & Chart | ROCKET PHARMACEUTICALS INC (NASDAQ:RCKT) - ChartMill
Rocket Pharmaceuticals CEO Gaurav Shah sells $9,837 in stock - Investing.com UK
Rocket Pharmaceuticals VP John Militello sells $3,083 in stock By Investing.com - Investing.com South Africa
Rocket Pharma general counsel Wilson sells $12,119 in stock - Investing.com UK
Rocket Pharma general counsel Wilson sells $12,119 in stock By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals CEO Gaurav Shah sells $9,837 in stock By Investing.com - Investing.com Australia
Rocket Pharmaceuticals VP John Militello sells $3,083 in stock - Investing.com
Rocket Pharmaceuticals (RCKT) counsel sells shares to cover RSU tax withholding - Stock Titan
Rocket Pharma (RCKT) CEO sells shares to cover RSU tax obligations - Stock Titan
Rocket Pharmaceuticals (RCKT) insider sells 855 shares for tax withholding - Stock Titan
RCKT (NASDAQ) Rule 144: Director sales listed; 3,361 vested shares - Stock Titan
[144] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan
RCKT (NASDAQ: RCKT) files Form 144 for 855 vested shares - Stock Titan
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Lifesci Capital Analysts Raise Earnings Estimates for RCKT - MarketBeat
TradingKey - TradingKey
Rocket Pharmaceuticals chief commercial officer sells $67,740 in stock By Investing.com - Investing.com Canada
Rocket Pharmaceuticals chief commercial officer sells $67,740 in stock - Investing.com India
Rocket Pharmaceuticals (RCKT) insider sale covers RSU tax obligations - Stock Titan
Rocket Pharmaceuticals pursues gene therapy advances at Heart Failure 26 to accelerate early diagnosis - Traders Union
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus - The Globe and Mail
Number of shareholders of Rocket Pharmaceuticals, Inc. – GETTEX:9IP1 - TradingView
0.98%
0.12%
자본화:
|
볼륨(24시간):